Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity

(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity

US Patent 7253211 · Granted Aug 7, 2007

Estimated economic value: $361,969,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrido-pyrimidinone and pteridinone compounds and methods of use2025
Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors2024
Agonists of stimulator of interferon genes sting2023
Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitors2021
Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors2021
Bruton's tyrosine kinase inhibitors2020
Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors2019
Bruton's tyrosine kinase inhibitors2019
Polysubstituted pyrroles having microtubule-disrupting, cytotoxic and antitumor 2018
Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors2018
Arginase inhibitors and methods of use thereof2016
Arginase inhibitors and methods of use thereof2014